Hamilton Locke has lost its opposition to the trade mark of a Sydney law firm, with a delegate finding the firms’ marks were not likely to cause confusion in the legal market.
News Corp-owned REA Group has sued rival real estate portal Domain, accusing its main competitor of infringing the copyright it owns in property photos and floor plans.
Bayer has filed a High Court challenge to a decision that invalidated its patents for blockbuster blood thinner Xarelto, saying it would adversely affect drug research and development.
Fast food giant McDonald’s has resolved its dispute over misleading burger ads by Hungry Jack’s, ending a heated four-year courtroom battle.
International currency exchange company Travelex has won its opposition to three trade marks by blockchain travel company Travelx.
The Full Court has overturned a finding that singer Katy Perry infringed an Australian fashion designer’s ‘Katie Perry’ mark, finding the designer knew of the pop star when she registered the mark.
As it fends off a suit by AstraZeneca seeking to block the sale of a cheaper version of Brilinta, generics maker Pharmacor claims a patent for the heart attack drug should not have been extended.
AI tech company Paige can’t patent a tool to provide quality control for analysis of pathology images, with IP Australia finding the invention is merely an “administrative scheme” to automate the role of human pathologists.
US animal drug manufacturer Zoetis has lost its challenge a ruling that chucked out three of its patents for a single-dose vaccine to protect pigs from enzootic pneumonia.
US men’s magazine Maxim is seeking an injunction against its “out of control” Australian licensee, which it accuses of running modelling tours for an offshoot brand that are below its standards.